Potassium chloride
Find information on thousands of medical conditions and prescription drugs.

K-Dur

The chemical compound potassium chloride (KCl) is a metal halide composed of potassium and chlorine. In its pure state it is odourless. It has a white to colourless vitreous crystal, with a face-centred cubic structure that cleaves easily in three directions. It is also commonly known as "Muriate of Potash". Potash varies in color from pink or red to white depending on the mining and recovery process used. White potash, sometimes referred to as soluble potash, is usually higher in analysis and is used primarily for making liquid starter fertilizers. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
Clonazepam
K-Dur
Kadian
Kainic acid
Kanamycin
Kantrex
Kariva
Kayexalate
Keflex
Kefzol
Kemstro
Keppra
Ketalar
Ketamine
Ketanserin
Ketek
Ketoconazole
Ketoprofen
Ketorolac
Ketotifen
Kionex
Klor-con
Klotrix
Konazol
Korostatin
Kytril
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

KCl is used in medicine, scientific applications, food processing and in judicial execution through lethal injection. It occurs naturally as the mineral sylvite and in combination with sodium chloride as sylvinite.

Chemical properties

Potassium chloride can react as a source of chloride ion. As with any other soluble ionic chloride, it will precipitate insoluble chlorides when added to a solution of an appropriate metal salt such as silver nitrate:

KCl(aq) + Ag(NO3)(aq) → AgCl(s) + KNO3(aq)

Although potassium is more electropositive than sodium, KCl can be reduced to the metal by reaction with metallic sodium if the potassium is removed by distillation, due to Le Chatelier's principle:

Read more at Wikipedia.org


[List your site here Free!]


The Federal Trade Commission last month ruled that Schering-Plough, Upsher-Smith Laboratories and American Home Products entered illegal agreements in
From Drug Store News, 1/19/04

The Federal Trade Commission last month ruled that Schering-Plough, Upsher-Smith Laboratories and American Home Products entered illegal agreements in 1997 and 1998 to delay the entry of lower-cost generic competition for Schering's prescription drug K-Dur 20, which is used to treat people with low potassium.

The new decision in effect reverses a July 2, 2002, decision of an FTC administrative law judge that ruled in favor of Schering.

According to the commission's opinion, Schering and its potential generic competitors, Upsher and AHP, had settled patent litigation with terms that included unconditional payments by Schering in return for agreements to defer introduction of the generic products to September 2001 and January 2004, respectively.

Schering-Plough plans to appeal the new decision, the company stated in a press release.

COPYRIGHT 2004 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2004 Gale Group

Return to K-Dur
Home Contact Resources Exchange Links ebay